Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Virchows Archiv : an International Journal of Pathology
|
May 9, 2020
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
Kristina A Tendl-Schulz, Fabian Rössler, Philipp Wimmer, et al.
NPJ Breast Cancer
|
April 8, 2026
Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial
Daniel Egle, Dominik Hlauschek, Simon Peter Gampenrieder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study
Martin Filipits, Urania Dafni, Michael Gnant, et al.
Breast (Edinburgh, Scotland)
|
November 6, 2025
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34
Stephanie Kacerovsky-Strobl, Christine Deutschmann, Dominik Hlauschek, et al.
Cancers
|
April 26, 2025
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma
Berta Mosleh, Katharina Sinn, Anna Cho, et al.
Clinical Lung Cancer
|
November 12, 2018
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer
Lesley Seymour, Gwénaël Le Teuff, Elisabeth Brambilla, et al.
Oncoimmunology
|
July 3, 2015
Myeloid <i>STAT3</i> promotes formation of colitis-associated colorectal cancer in mice
Paulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2021
Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
Qing Zhou, Simon P Gampenrieder, Sophie Frantal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy
Frances A Shepherd, Caroline Domerg, Pierre Hainaut, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 5, 2014
Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy
Karin Schelch, Mir A Hoda, Thomas Klikovits, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Virchows Archiv : an International Journal of Pathology
|
May 9, 2020
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
Kristina A Tendl-Schulz, Fabian Rössler, Philipp Wimmer, et al.
NPJ Breast Cancer
|
April 8, 2026
Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial
Daniel Egle, Dominik Hlauschek, Simon Peter Gampenrieder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2018
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study
Martin Filipits, Urania Dafni, Michael Gnant, et al.
Breast (Edinburgh, Scotland)
|
November 6, 2025
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34
Stephanie Kacerovsky-Strobl, Christine Deutschmann, Dominik Hlauschek, et al.
Cancers
|
April 26, 2025
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma
Berta Mosleh, Katharina Sinn, Anna Cho, et al.
Clinical Lung Cancer
|
November 12, 2018
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer
Lesley Seymour, Gwénaël Le Teuff, Elisabeth Brambilla, et al.
Oncoimmunology
|
July 3, 2015
Myeloid <i>STAT3</i> promotes formation of colitis-associated colorectal cancer in mice
Paulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2021
Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
Qing Zhou, Simon P Gampenrieder, Sophie Frantal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2013
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy
Frances A Shepherd, Caroline Domerg, Pierre Hainaut, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 5, 2014
Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy
Karin Schelch, Mir A Hoda, Thomas Klikovits, et al.
Page
of 13